Advertisement

A tracer molecule designed to bind to amyloid plaques, the neurological hallmark of Alzheimer's disease, can accurately detect the protein in the living human brain, according to a new study published this week in the Journal of the American Medical Association. Previously, the only definitive way to detect amyloid in the brain, and hence diagnose the disease, was via an autopsy.

SOURCE

Advertisement
Advertisement